These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18186575)

  • 1. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection.
    Khiani V; Kelly T; Shibli A; Jensen D; Mohanty SR
    World J Gastroenterol; 2008 Jan; 14(2):318-21. PubMed ID: 18186575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alpha 2b in a patient with HIV/HCV coinfection: case report].
    Bassetti BR; Trés ES; Ciríaco JG; Pinto Neto LF
    Rev Soc Bras Med Trop; 2010; 43(1):89-91. PubMed ID: 20305976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis C virus infection: a case report.
    Lahbabi M; Ghissassi M; Belahcen F; Ibrahimi SA; Aqodad N
    J Med Case Rep; 2012 Sep; 6():278. PubMed ID: 22947101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of chronic inflammatory demyelinating polyradiculoneuropathy after treatment with pegylated interferon α-2a in a patient with chronic hepatitis B virus infection].
    Naito H; Takeda I; Segawa A; Tsuge M; Maruyama H; Matsumoto M
    Rinsho Shinkeigaku; 2016 Oct; 56(10):672-677. PubMed ID: 27680223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C.
    Choi JW; Lee JS; Paik WH; Song TJ; Kim JW; Bae WK; Kim KA; Kim JG
    Clin Mol Hepatol; 2016 Mar; 22(1):168-71. PubMed ID: 27044768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of Bell's palsy associated with peginterferon Alfa-2a and ribavirin therapy for chronic hepatitis C virus infection].
    Lee MY; Cho H; Kim YM; Lee JS
    Korean J Hepatol; 2006 Sep; 12(3):444-8. PubMed ID: 16998297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral polyneuropathy and bilateral optic neuropathy during treatment of chronic hepatitis C].
    Chrissafidou A; Musch E
    Dtsch Med Wochenschr; 2009 Apr; 134(18):927-30. PubMed ID: 19384811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection.
    Akhan SC; Kalender B; Ruzgar M
    Infection; 2008 Aug; 36(4):341-4. PubMed ID: 18629437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum transaminase elevations during pegylated interferon treatment of chronic HCV hepatitis probably induced by polyethylene glycol.
    Caroleo B; Gallelli L; Staltari O; De Sarro G; Guadagnino V
    Intervirology; 2008; 51(6):407-9. PubMed ID: 19258719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
    Ogawa E; Furusyo N; Kajiwara E; Takahashi K; Nomura H; Tanabe Y; Satoh T; Maruyama T; Nakamuta M; Kotoh K; Azuma K; Dohmen K; Shimoda S; Hayashi J;
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1233-40. PubMed ID: 22098185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis.
    Kim SR; Imoto S; Mita K; Taniguchi M; Sasase N; Muramatsu A; Kudo M; Kitai S; El-Shamy A; Hotta H; Hayashi Y
    Digestion; 2009; 79(1):36-9. PubMed ID: 19246919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?
    Gluhovschi C; Gadalean F; Kaycsa A; Curescu M; Sporea I; Gluhovschi G; Petrica L; Velciov S; Bozdog G; Bob F; Vernic C; Cioca D
    Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):744-50. PubMed ID: 21320001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].
    Halász T; Farkas A; Tolvaj G; Horváth G
    Orv Hetil; 2006 Feb; 147(7):321-4. PubMed ID: 17489160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C].
    Son BK; Sohn JH; Kim TY; Park YK; Jeon YC; Han DS
    Korean J Hepatol; 2007 Mar; 13(1):103-7. PubMed ID: 17380081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C.
    Song JS; Sohn JH; Jeong JY; Min JH; Choi WS; Kim OZ; Pyo JY
    Korean J Gastroenterol; 2016 May; 67(5):272-276. PubMed ID: 27206440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
    Berenguer J; González-García J; López-Aldeguer J; Von-Wichmann MA; Quereda C; Hernando A; Sanz J; Tural C; Ortega E; Mallolas J; Santos I; Miralles P; Montes ML; Bellón JM; Esteban H;
    J Antimicrob Chemother; 2009 Jun; 63(6):1256-63. PubMed ID: 19363085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.
    Laguno M; Cifuentes C; Murillas J; Veloso S; Larrousse M; Payeras A; Bonet L; Vidal F; Milinkovic A; Bassa A; Villalonga C; Pérez I; Tural C; Martínez-Rebollar M; Calvo M; Blanco JL; Martínez E; Sánchez-Tapias JM; Gatell JM; Mallolas J
    Hepatology; 2009 Jan; 49(1):22-31. PubMed ID: 19085908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha.
    Hirotani M; Nakano H; Ura S; Yoshida K; Niino M; Yabe I; Sasaki H
    Intern Med; 2009; 48(5):373-5. PubMed ID: 19252365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection.
    Chan TM; Ho SK; Tang CS; Tse KC; Lam MF; Lai KN; Yung S
    Nephrology (Carlton); 2007 Feb; 12(1):11-7. PubMed ID: 17295655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
    Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
    Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.